Two-drug synergy may treat drug-resistant chronic myeloid leukemia
Wednesday, October 24, 2012 - 12:31
in Health & Medicine
Researchers have dissected a case of synergy in drug-resistant chronic myeloid leukemia to understand the mechanism by which two drugs, danusertib and bosutinib, work together to overcome resistance in the BCR-ABL gatekeeper mutation-specific disease.